These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 380080)
1. Orthotopic bone transplantation in mice. I. Technique and assessment of healing. Halloran PF; Ziv I; Lee EH; Langer F; Pritzker KP; Gross AE Transplantation; 1979 Jun; 27(6):414-9. PubMed ID: 380080 [TBL] [Abstract][Full Text] [Related]
2. Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice. Hori J; Streilein JW Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1820-8. PubMed ID: 11431448 [TBL] [Abstract][Full Text] [Related]
3. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Hori J; Streilein JW Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):720-6. PubMed ID: 11222533 [TBL] [Abstract][Full Text] [Related]
4. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573 [TBL] [Abstract][Full Text] [Related]
5. Orthotopic bone transplantation in mice. II. Studies of the alloantibody response. Halloran PF; Lee EH; Ziv I; Langer F; Gross AE Transplantation; 1979 Jun; 27(6):420-6. PubMed ID: 380081 [TBL] [Abstract][Full Text] [Related]
6. Orthotopic bone transplantation in mice. III. Methods of reducing the immune response and their effect on healing. Kliman M; Halloran PF; Lee E; Esses S; Fortner P; Langer F Transplantation; 1981 Jan; 31(1):34-40. PubMed ID: 7233526 [TBL] [Abstract][Full Text] [Related]
7. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Sonoda Y; Sano Y; Ksander B; Streilein JW Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631 [TBL] [Abstract][Full Text] [Related]
9. Donor marrow-derived cells as immunogens and targets for the immune response to bone and skin allografts. Esses SI; Halloran PF Transplantation; 1983 Feb; 35(2):169-74. PubMed ID: 6338635 [TBL] [Abstract][Full Text] [Related]
10. Studies of the behaviour of allogeneic cancellous bone grafts in inbred rats. Elves MW Transplantation; 1975 May; 19(5):416-23. PubMed ID: 1098244 [TBL] [Abstract][Full Text] [Related]
11. [Experimental study on rejection of allogeneic donor bone marrow cells in sensitized recipients]. Xu LH; Fang JP; Weng WJ; Xu HG; Ye QX Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):734-8. PubMed ID: 22339907 [TBL] [Abstract][Full Text] [Related]
12. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10). Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464 [TBL] [Abstract][Full Text] [Related]
13. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection? Dennert G; Anderson CG; Warner J J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning. Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556 [TBL] [Abstract][Full Text] [Related]
15. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. Peeler JS; Niederkorn JY J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767 [TBL] [Abstract][Full Text] [Related]
16. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection. Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343 [TBL] [Abstract][Full Text] [Related]
17. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Sano Y; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710 [TBL] [Abstract][Full Text] [Related]
18. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice. Yamada J; Kurimoto I; Streilein JW Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657 [TBL] [Abstract][Full Text] [Related]
19. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition. Sano Y; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658 [TBL] [Abstract][Full Text] [Related]
20. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells. Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]